Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

KMZ reported for the months of 2024 by RAS

7/9/24 KMEZ

Sollers to relaunch former Isuzu site in Q4

7/9/24 SVAV

NLMK's machine builders manufactured a railcar dumper for the first time

7/9/24 NLMK

GAZ recovered ₽16.9 billion from Volkswagen

7/9/24 GAZA

Yandex Go launches electric scooter rental service in Uzbekistan

7/9/24 YDEX

Sberbank reported for 6 months of 2024 by RAS

7/9/24 SBER

Shareholders of Transneft approved dividends for 2023

7/8/24 TRNFP

LSR intends to implement five development projects in the UAE

7/8/24 LSRG

VinLab sales grew by 32.5%

7/8/24 BELU

Inter RAO wants to buy Himprom

7/8/24 HIMCP